Is the third generation EGFR TKIs the solution for making EGFR mutant NSCLC a curable disease?

Saved in:
Bibliographic Details
Published inTranslational lung cancer research Vol. 3; no. 6; pp. 363 - 364
Main Author Hirsch, Fred R
Format Journal Article
LanguageEnglish
Published China Pioneer Bioscience Publishing Company 01.12.2014
Online AccessGet full text

Cover

More Information
ISSN:2218-6751
2226-4477
DOI:10.3978/j.issn.2218-6751.2014.11.07